| 書目名稱 | Metal Compounds in Cancer Therapy | | 編輯 | Simon P. Fricker | | 視頻video | http://file.papertrans.cn/632/631409/631409.mp4 | | 圖書封面 |  | | 描述 | The discovery of the antitumour activity of cisplatin in 1965 and its subsequent introduction into clinical trials in 1971 was the catalyst for a major international research effort investigating the potential of metal compounds in cancer therapy. Cisplatin now occupies an important place in the armamentarium of the oncologist due to its effectiveness in the treatment of testicular cancer. A second generation analogue, carbo- platin, offers reduced toxicity together with therapeutic activity, which gives it a place in the front-line therapy of genitourinary cancers. These and other successes have encouraged the search for novel metal-based drugs for cancer therapy. Research has shown that metal compounds have potential for activity not only as cytotoxic antitumour agents, but also in areas such as adjuvant therapy, diagnosis and immunotherapy. The aim of this book is to review and describe the major achievements and developments arising from this international research effort. The contributing authors come from labora- tories throughout Europe and America and represent the many disci- plines characteristic of this research, such as clinical research, pharmacology, tumour biology an | | 出版日期 | Book 1994 | | 關(guān)鍵詞 | cancer; cancer therapy; clinical trial; imaging; research; tumor | | 版次 | 1 | | doi | https://doi.org/10.1007/978-94-011-1252-9 | | isbn_softcover | 978-94-010-4545-2 | | isbn_ebook | 978-94-011-1252-9 | | copyright | Springer Science+Business Media Dordrecht 1994 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-18 18:55
發(fā)表于 2025-3-21 17:28:50
